Invention Grant
- Patent Title: Inhibitors of metallo-beta-lactamase (MBL) comprising a zinc chelating moiety
-
Application No.: US15027140Application Date: 2014-10-06
-
Publication No.: US10227327B2Publication Date: 2019-03-12
- Inventor: Pål Rongved , Ove Alexander Høgmoen Åstrand , Annette Bayer , Hanna-Kirsti Schrøder Leiros , Ørjan Samuelsen , Kine Susann Waade Edvardsen , Zeeshan Muhammad
- Applicant: Universitetet I Oslo
- Applicant Address: NO Oslo
- Assignee: Universitetet | Oslo
- Current Assignee: Universitetet | Oslo
- Current Assignee Address: NO Oslo
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB1317619.3 20131004
- International Application: PCT/GB2014/053009 WO 20141006
- International Announcement: WO2015/049546 WO 20150409
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61P31/04 ; C07D401/14 ; A61K31/444 ; A61K38/05 ; C07D405/14 ; C07K5/062 ; A61K47/64

Abstract:
Compounds according to formula I are provided: A-L-B wherein A represents a lipophilic chelating moiety which is selective for Zn2+ ions; L is a covalent bond or a linker; and B is a vector which is either a moiety capable of interacting with one or more biological structures found in a bacterium (preferably in a bacterial cell wall), for example a penicillin-binding protein such as a metallo-β-lactamase or DD-transferase, or a moiety capable of enhancing transport of the compound across a bacterial cell membrane. A method of treating and/or preventing a bacterial infection in a human or non-human mammal employing such compounds are also provided. In such a method, the compound of formula I may be administered in combination with (either simultaneously, separately, or sequentially) a β-lactam antibiotic.
Public/Granted literature
- US20160244431A1 Inhibitors of Metallo-Beta-Lactamase (MBL) Comprising a Zinc Chelating Moiety Public/Granted day:2016-08-25
Information query